The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting is taking place in Washington, D.C., and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brings together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.

VJHemOnc caught up with the presenters on new research studies and clinical trials. Move videos coming soon!

 

SITC 2021

SITC 2021
10–14 November 2021 | Washington D.C.

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

SITC 2021

SITC 2021
10–14 November 2021 | Washington D.C.

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting is taking place in Washington, D.C., and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brings together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.

VJHemOnc caught up with the presenters on new research studies and clinical trials. Move videos coming soon!

 

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter